Advanced heart failure with reduced ejection fraction

Proceedings
Albert HicksJeffrey B Michel

Abstract

Patients suffering advanced heart failure with reduced ejection fraction (HFrEF) account for a large portion of patients admitted to hospitals worldwide. Mortality and 30-day readmission rates for HFrEF are now a focus of value-based payment models, making management of this disease a priority for hospitals, physicians, and payers alike. Angiotensin-converting enzyme inhibitors have been the cornerstone of therapy for decades. However, with treatment, the prognosis for patients with advanced HFrEF remains poor. Fortunately, advances in medical therapy and mechanical support offer some patients improvement in both survival and quality of life. We review advances in short- and long-term mechanical support and explore changes to organ allocation for cardiac transplantation. In addition, we provide a guide to facilitate appropriate referral to an advanced heart failure team.

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Nov 1, 1964·American Journal of Surgery·C W HALLM E DEBAKERY
Jan 31, 2004·The Journal of Thoracic and Cardiovascular Surgery·Robert D DowlingO H Frazier
Apr 21, 2005·JAMA : the Journal of the American Medical Association·Jonathan D Sackner-BernsteinKeith Aaronson
May 24, 2012·Circulation·Keith D AaronsonUNKNOWN HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators
Sep 2, 2014·The New England Journal of Medicine·John J V McMurrayUNKNOWN PARADIGM-HF Investigators and Committees
Jan 23, 2015·The Cochrane Database of Systematic Reviews·Ralph TrammCarol Hodgson
Feb 29, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·James K KirklinJenny Lannon
Jul 11, 2016·JACC. Heart Failure·Vanessa XanthakisRamachandran S Vasan
Aug 9, 2016·Journal of Thoracic Disease·Matteo PozziJean François Obadia
Oct 25, 2016·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Lars H LundUNKNOWN International Society for Heart and Lung Transplantation
Dec 14, 2016·The New England Journal of Medicine·Mandeep R MehraUNKNOWN MOMENTUM 3 Investigators
Feb 2, 2017·The New England Journal of Medicine·Joseph G RogersCarmelo A Milano
Feb 16, 2017·European Journal of Heart Failure·Finn Gustafsson, Joseph G Rogers
Sep 10, 2017·Critical Care Clinics·Christopher S KingRamesh Singh
Sep 22, 2017·Current Transplantation Reports·David A Baran
Oct 17, 2017·Anaesthesia Critical Care & Pain Medicine·Arthur Le GallRomain Pirracchio
Oct 19, 2017·Journal of Critical Care·Terri SunHussein D Kanji
Jan 20, 2018·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·C L MeuweseD W Donker
May 29, 2018·Circulation·Mandeep R MehraScott C Silvestry
Jul 17, 2018·JACC. Heart Failure·Carmelo A MilanoUNKNOWN ENDURANCE Investigators
Jul 24, 2018·Journal of Thoracic Disease·Tariq LescouflairAhmet Kilic
Oct 26, 2018·Circulation. Heart Failure·Muddassir Mehmood
Oct 26, 2018·Circulation. Heart Failure·Prashant RaoRobb D Kociol
Feb 16, 2019·Journal of the American College of Cardiology·Maya GuglinSean P Pinney
Mar 9, 2019·Cardiac Failure Review·Tonje Thorvaldsen, Lars H Lund
Mar 12, 2019·Annals of Cardiothoracic Surgery·Gaik NersesianFelix Schoenrath
Mar 19, 2019·The New England Journal of Medicine·Mandeep R MehraUNKNOWN MOMENTUM 3 Investigators
Apr 5, 2019·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Yuryi PyaIvan Netuka
May 23, 2019·Current Opinion in Critical Care·Marc Pineton de ChambrunAlain Combes
Jun 12, 2019·Journal of Thoracic Disease·Vitaly PoptsovElizaveta Zolotova
Jul 20, 2019·Interactive Cardiovascular and Thoracic Surgery·Marian UrbanJohn Um

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.